- Home
- ARTW vs ADXN Comparison
ARTW vs ADXN Comparison
Compare ARTW & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARTW | ADXN |
|---|---|---|
| Founded | 1956 | 2002 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 10.3M |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ARTW | ADXN |
|---|---|---|
| Price | $2.21 | $6.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 49.5K | 1.2K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 233.33 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $22,975,408.00 | N/A |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.20 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.43 | $6.29 |
| 52 Week High | $4.69 | $12.05 |
Technical Indicators
Market Signals| Indicator | ARTW | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 43.14 | 41.75 |
| Support Level | $2.12 | $6.84 |
| Resistance Level | $2.49 | $8.74 |
| Average True Range (ATR) | 0.17 | 0.29 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 13.41 | 34.10 |
Price Performance
Historical ComparisonAbout ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.